Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ADOT - BIOMODA: Profitable Technology with Purpose -- Ignore unavailable to you. Want to Upgrade?

To: BIGFRED who wrote (1414)	8/3/1998 10:47:00 AM
From: garyb	Read Replies (2) \| Respond to of 4650

Hi Bigfred, Your statement that ADOT owns 21% of Biomoda does not concur with the company press release dated 6/11. <<. Advanced Optics Electronics actively seeks partnerships with companies in fields that could benefit from ADOT's patented technology. ADOT also owns in excess of 27% of Biomoda, Inc., an emerging biotechnology company specializing in breakthrough cancer diagnostics and therapy. Advanced Optics Electronics, Inc. has retained first right of refusal to design,manufacture and distribute the necessary scanning testing devices for the lung cancer tests using Advanced Optics Electronics' proprietary display technology.>> An earlier post indicated that Biomoda's CEO said that ADOT does not have the first right of refusal to design, manufacture and distribute scanning testing devices for the lung cancer tests. I want to know who is telling the truth. Have to believe that ADOT would not send out a PR if it weren't true, would you? cheers GaryB